Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.

Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.

Read more

Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis.

Read more

Potentiation of glucocorticoid receptor (GR)-mediated signaling by the immunosuppressant tacrolimus in rheumatoid synoviocytes.

Read more

Will Jill come tumbling after? The case for a JAK2-type mutation as a prequel to the connective tissue disorders.

Read more

Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis.

Read more

Vasculopathy and pulmonary arterial hypertension.

Read more

Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Read more

Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?

Read more

Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

Read more

Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.

Read more

Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment.

Read more

Beneficial effects of cellular stress response in traditional spa treatment of rheumatoid arthritis.

Read more

Contact Us

Have questions about Stem Cell Therapy?
Fill out the form or contact us below and we’ll be in touch!

Join the Revolution

Learn how to take your practice to the next level. Set up a consultation below